Viatris Operating Cash Flow decreased by 52.4% to $388.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 27.5%, from $535.50M to $388.30M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -6.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $559.40M | $1.09B | $523.10M | $1.14B | $802.50M | $869.00M | $189.00M | $971.20M | $525.10M | $835.20M | $568.50M | $614.60M | $379.10M | $826.50M | $482.70M | $535.50M | $219.70M | $744.90M | $815.80M | $388.30M |
| QoQ Change | — | +94.1% | -51.8% | +117.6% | -29.5% | +8.3% | -78.3% | +413.9% | -45.9% | +59.1% | -31.9% | +8.1% | -38.3% | +118.0% | -41.6% | +10.9% | -59.0% | +239.1% | +9.5% | -52.4% |
| YoY Change | — | — | — | — | +43.5% | -20.0% | -63.9% | -14.7% | -34.6% | -3.9% | +200.8% | -36.7% | -27.8% | -1.0% | -15.1% | -12.9% | -42.0% | -9.9% | +69.0% | -27.5% |